Impaza, tablets 20 pcs
€17.36 €14.47
Enhances endothelial NO synthase activity, restores endothelial production of nitric oxide (NO) during sexual stimulation, increases the content of cyclic guanosine-2 monophosphate (cGMP) in smooth muscles and promotes their relaxation, which leads to increased blood filling of cavernous bodies and provides an erection of sufficient strength and duration. The drug increases libido (libido) and sexual satisfaction. Regular use of the drug increases the level of testosterone in the serum (at a moderately reduced baseline< br>).
Pharmacokinetics
The sensitivity of modern physicochemical methods of analysis< br> (gas-liquid chromatography, high-performance liquid< br> Chromatography, chromatography-mass spectrometry) does not allow to estimate the content of the active ingredient of Impaza in biological fluids, organs and tissues due to the specific composition of the drug (see “Composition (1 tablet)”). See section “Composition (per tablet)”), which makes it technically impossible to study pharmacokinetics.
Indications
Impaza is indicated for use in adults.
Erectile dysfunction (erectile dysfunction) of various origins.
Active ingredient
Antibodies
Composition
Active ingredients:
Antibodies to endothelial NO synthase affinity purified – 0.003 g *.
Excipients: lactose monohydrate 0.267 g, microcrystalline cellulose 0.03 g, magnesium stearate 0.003 g.
*Lactose monohydrate in the form of an aqueous-alcoholic mixture containing not more than 10 -15 ng/g of the active form of the active ingredient.
How to take, the dosage
Risk is not intended to divide the tablet into parts.
At one reception – 1 tablet (keep in the mouth until dissolved – not during meals).
For improvement of erection (ability to have sexual intercourse) it is recommended to make a course of treatment and prophylaxis during at least 12 weeks
1 tablet 1-2 times a day.
If necessary the course therapy may be repeated in 3-6 months.
Interaction
It is possible to use Impaza while taking nitrates in patients with coronary heart disease (angina pectoris I-II functional class), as well as when used together with beta-adrenoblockers, diuretics, angiotensin-converting enzyme inhibitors (ACE), calcium antagonists.
Special Instructions
The drug contains lactose monohydrate; therefore, it is not recommended for patients with congenital galactosemia, glucose or galactose malabsorption syndrome, or congenital lactase deficiency.
Synopsis
The tablets are flat and cylindrical, rimmed and beveled, white to almost white. The flat side with the rib is labeled MATERIA MEDICA, the other flat side is labeled IMPAZA.
Contraindications
Increased individual sensitivity to the drug components; age under 18 years; lactase deficiency, lactose intolerance, glucose-galactose malabsorption.
Side effects
Possible reactions of individual hypersensitivity to the components of the drug.
.
Overdose
In case of an accidental overdose, dyspeptic phenomena due to the excipients included in the drug formulation are possible.
Pregnancy use
The drug Impaza is not intended for use in women.
Similarities
Proproten-100, Anaferon, Tenoten, Afala, Colophort, Regaline, Arthrophon, Divase, Afalase, Tenoten for children, Anaferon for children
Weight | 0.016 kg |
---|---|
Shelf life | 3 years. Do not use after the expiration date. |
Conditions of storage | In the dark place at a temperature not exceeding 25 ° C. Keep out of reach of children. |
Manufacturer | Materiala Medica Holding, Russia |
Medication form | lozenges |
Brand | Materiala Medica Holding |
Related products
Buy Impaza, tablets 20 pcs with delivery to USA, UK, Europe and over 120 other countries.